Journal of the American Society of Cytopathology

SJR Rank #8,520H-index: 28SJR: 0.681Best quartile: Q2APC: US$3,050
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Pathology and Forensic MedicineQ2

Areas: Medicine

Most published research topics

Cervical Cancer and HPV ResearchThyroid Cancer Diagnosis and TreatmentPancreatic and Hepatic Oncology ResearchAI in cancer detectionLung Cancer Diagnosis and TreatmentSalivary Gland Tumors Diagnosis and TreatmentHead and Neck Cancer StudiesLung Cancer Treatments and MutationsBladder and Urothelial Cancer TreatmentsDiverse Scientific and Economic Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04590135180

Documents per Year

20222025020406080

Detailed Information

ISSN

2213-2945

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

2.56

References per Document

32.84

Coverage

2012-2026

Scope

JASC is the official journal of the American Society of Cytopathology,and reflects the values and priorities of the society.. JASC publishes regular bimonthly issues with cutting-edge original research of the highest standard. The Journal seeks to provide an exceptional forum for interaction and dissemination of original research and educational information in the field of cytopathology and other allied disciplines in medicine. The cross-disciplinary focus of the journal ensures the sharing of information with all readers involved in the practice of cytopathology and its related basic sciences, epidemiology and clinical oncologic disciplines. JASC endeavors to have a positive impact not only on all aspects of cancer diagnosis and treatment, but also on other human disease. JASC publishes original work emphasizing novel discoveries or clinicopathologic correlations in a patient-centered environment, technological advances in basic and translational research with emphasis on the development of personalized medicine, and new or improved molecular techniques and their novel application for diagnosis or monitoring of disease. Preference is also given to original work demonstrating the scholarship of education in cytopathology including new innovative tools for continuing education and training as well as designing and implementing new assessment and evaluation techniques. It duly addresses and highlights issues relating to population health and public policy topics. It is the goal of JASC to lead the discipline of cytopathology by setting professional quality standards ensuring diagnostic excellence, advocating laboratory safety and quality, and inter-professional education for pathologists, cytotechnologists and all allied health care specialties.

Metrics from SCImago Journal Rank 2025. View on SCImago